ExCellThera

OverviewSuggest Edit

ExCellThera is a company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. It provides ECT-001, a technology that combines a small molecule, UM171, and an optimized culture system.
TypePrivate
Founded2015
HQMontréal, CA
Websiteexcellthera.com

Latest Updates

Employees (est.) (Sept 2021)20(+12%)
Cybersecurity ratingBMore

Key People/Management at ExCellThera

Guy Sauvageau

Guy Sauvageau

Scientific Founder, Chief Executive Officer, and Chief Scientific Officer
Anne Marinier

Anne Marinier

Scientific Founder, Secretary and Chief Technology Officer – Chemistry
Peter Zandstra

Peter Zandstra

Scientific Founder and Chief Technology Officer – Engineering and Production
Pierre Caudrelier

Pierre Caudrelier

Chief Medical Officer and Acting Operation Officer
Show more

ExCellThera Office Locations

ExCellThera has an office in Montréal
Montréal, CA (HQ)
2950 Chemin de Polytechnique
Show all (1)

ExCellThera Financials and Metrics

Summary Metrics

Founding Date

2015

ExCellThera total Funding

$6 m

ExCellThera latest funding size

$6 m

Time since last funding

2 years ago
ExCellThera's latest funding round in February 2020 was reported to be $6 m. In total, ExCellThera has raised $6 m
Show all financial metrics

ExCellThera Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

ExCellThera Online and Social Media Presence

Embed Graph

ExCellThera News and Updates

ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells

MONTREAL, July 13, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today announced that it has entered into a licensing agreement with Astella…

Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health

MONTREAL, April 21, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, and Ossium Health, a therapeutics company harnessing the power of stem cell sci…

ExCellThera receives Priority Medicines (PRIME) designation from European Medicines Agency for ECT-001 Cell Therapy

MONTREAL, Dec. 11, 2020 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that ECT-001 Cell Therapy has been granted PRIority MEdicines (PRIME) des…

ExCellThera Frequently Asked Questions

  • When was ExCellThera founded?

    ExCellThera was founded in 2015.

  • Who are ExCellThera key executives?

    ExCellThera's key executives are Guy Sauvageau, Anne Marinier and Peter Zandstra.

  • How many employees does ExCellThera have?

    ExCellThera has 20 employees.

  • Who are ExCellThera competitors?

    Competitors of ExCellThera include Chempolis, Plasticell and Cell Tissue Technology.

  • Where is ExCellThera headquarters?

    ExCellThera headquarters is located at 2950 Chemin de Polytechnique, Montréal.

  • Where are ExCellThera offices?

    ExCellThera has an office in Montréal.

  • How many offices does ExCellThera have?

    ExCellThera has 1 office.